CVS launches new brand targeting biosimilar market

CVS Health Corporation (CVS) is entering the biosimilar space with its new subsidiary brand Cordavis. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down what the brand entails and its impact on the company.